Institutional Giants Bet Big on Hims & Hers Stock
Published on 12/02/2025 at 14:45 | Redaktion boerse-global.de
A wave of aggressive buying by major financial institutions has swept over Hims & Hers Health, Inc. Recent regulatory filings reveal a stunning accumulation of shares by some of Wall Street’s most prominent players during the third quarter of 2025, signaling a powerful vote of confidence despite recent stock price volatility.
Leading the charge was JPMorgan Chase, which bolstered its portfolio by approximately 15.04 million shares—a staggering increase of 549%. This move represents an investment estimated at $853 million. The banking giant was not alone in its bullish stance. Tidal Investments amplified its stake by an extraordinary 1,779%, while asset manager T. Rowe Price reported a 444% increase in its holdings. Farallon Capital also significantly Read more...
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
